And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 treatments, with several promising candidates in the pipeline. These experimental ...
HELLO! speaks to nutritionist and exercise scientist Amelia Phillips and GP Dr Crystal Wyllie for the low down on weight loss ...
Eli Lilly announced trial results for its weight-loss medication, orforglipron, in August. Orforglipron is a once-daily oral ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. What Happens If You Use Expired Semaglutide? Wondering what ...
"Ozempic 2.0" has been floating around online, as a trending nickname for the next generation of weight loss drugs that are in the works.
The companies that manufacture Ozempic and Mounjaro are set to launch a new weight loss drug that doesn't involve needles.
Berberine is an alkaloid compound found in plants with over 400-500 species. It has recently become popular as a potential ...
New Scientist on MSN
Daily pill could offer alternative to weight-loss injections
Orforglipron, a GLP-1 drug taken as a pill, achieved positive results in people with obesity and type 2 diabetes, although it ...
A new oral GLP-1 receptor agonist, orforglipron, is revolutionizing weight management by offering a needle-free alternative ...
Okava Pharmaceuticals, a biopharmaceutical company, has launched a pilot study of a GLP-1 drug for cats with obesity ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback